Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Alarcon

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE)Farida Gorram, Flora Alarcon, Hervé Perdry, et al.
Journal of Medical Genetics|December 18, 2013
A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screeningBernard Bonaïti, Flora Alarcon, Nadine Andrieu, et al.
Genome Medicine|August 3, 2022
Publisher Correction: Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypesCatherine Schramm, Camille Charbonnier, Aline Zaréa, et al.
Genome Medicine|June 27, 2022
Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypesCatherine Schramm, Camille Charbonnier, Aline Zaréa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 20, 2020
Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk predictionNadim Hamzaoui, Flora Alarcon, Nicolas Leulliot, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 30, 2023
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosisViolaine Planté-Bordeneuve, Farida Gorram, Malin Olsson, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE)Farida Gorram, Flora Alarcon, Hervé Perdry, et al.
Journal of Medical Genetics|December 18, 2013
A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screeningBernard Bonaïti, Flora Alarcon, Nadine Andrieu, et al.
Genome Medicine|August 3, 2022
Publisher Correction: Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypesCatherine Schramm, Camille Charbonnier, Aline Zaréa, et al.
Genome Medicine|June 27, 2022
Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypesCatherine Schramm, Camille Charbonnier, Aline Zaréa, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 20, 2020
Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk predictionNadim Hamzaoui, Flora Alarcon, Nicolas Leulliot, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 30, 2023
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosisViolaine Planté-Bordeneuve, Farida Gorram, Malin Olsson, et al.
Pageof 2